Specializing In:Evaluation and treatment of patients with hematologic disorders such as leukemia, lymphoma, and myeloma for bone marrow transplant.
About Christine Ho
I am currently a staff physician in the Transplant and Cellular Therapy Department at Roswell Park Comprehensive Cancer Center. I developed a strong interest in this field during my fellowship training at Rutgers Cancer Institute of New Jersey. My research has focused both on strategies to prevent graft versus host disease and on harnessing the immune system to target certain cancers. I am the Principal Investigator on a Phase Ib/2 clinical trial of Fludarabine/Melphalan/Total Body Irradiation with Post Transplant Cyclophosphamide as graft versus host disease prophylaxis in matched-related and matched-unrelated allogeneic hematopoietic cell transplantation. Additionally, I am actively doing research in the field of multiple myeloma and adoptive cellular therapy. I recently published a paper in Blood Advances titled: Immune Signatures Associated with Improved Progression Free and Overall Survival for Myeloma Patients Treated with AHCT. I am a co-leader of the Adoptive Cellular Therapy program at Roswell Park. I am the Principal Investigator of clinical trials utilizing NK cell and T cell-directed therapy for multiple myeloma with the goal of improving outcomes and survival. I am dedicated and committed to providing comprehensive care for all my patients.
Roswell Park Comprehensive Cancer Center
- Assistant Professor of Oncology
- Transplant and Cellular Therapy Center
- Department of Medicine
Education and Training:
- 2008 - MD - Albert Einstein College of Medicine, Bronx, NY
- 2011 - Internal Medicine, Brown University, Providence, RI
- 2015 - Hematology/Oncology, Rutgers Cancer Institute of New Jersey/Robert Wood Johnson Medical School, New Brunswick, NJ
- Internal Medicine
- American Society of Hematology
- American Society of Blood and Marrow Transplantation